Polomar Health ServicesPMHS 33 EBITDA Margin % is 0.30% as of Mar. 2026. GuruFocus rates PMHS with a GF Score™ of 33/100 and a GF Value™ of $12.34 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Polomar Health Services ranks worse than 86.23% on this metric.
Polomar Health Services (OTCPK:PMHS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Polomar Health Services EBITDA Margin % Related Terms
Polomar Health Services EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMHS vs RDGT, DHTI, BLMH: EBITDA Margin % Comparison
For the Pharmaceutical Retailers subindustry, Polomar Health Services's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polomar Health Services EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Polomar Health Services's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polomar Health Services (PMHS) has a EBITDA Margin % of 0.30% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Polomar Health Services and its competitors. According to the industry distribution chart, Polomar Health Services ranks #576 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 86.2%.
Is Polomar Health Services' EBITDA Margin % too high?
Polomar Health Services' current EBITDA Margin % is 0.30%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Polomar Health Services' value of 0.30% is 97.1% below this industry median. Based on the distribution chart, Polomar Health Services ranks #576 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Polomar Health Services has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' EBITDA Margin % compare to RDGT and DHTI?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #576 out of 668 companies for EBITDA Margin %. This places Polomar Health Services in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Polomar Health Services' value of 0.30% is 97.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polomar Health Services's current EBITDA Margin % of 0.30% is 97.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current EBITDA Margin % is 0.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.34, compared to a current price of $0.14 — trading 98.8% below its estimated fair value. The current EBITDA Margin % is 0.30% and 97.1% below the Healthcare Providers & Services industry median of 10.21. Polomar Health Services' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current EBITDA Margin % is 0.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polomar Health Services (PMHS) Overvalued in 2026?
Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued.
The current stock price of $0.14 is trading 98.8% below its estimated GF Value™ of $12.34.
GuruFocus considers Polomar Health Services to be Possible Value Trap.
Key valuation signals for PMHS:
EBITDA Margin %: 0.30%
GF Value™: $12.34 vs. price of $0.14 (98.8% below fair value)
Industry Position: 97.1% below the Healthcare Providers & Services median (#576 of 668)
No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
33GF Score
Get the complete analysis for PMHS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMHS has been successfully added to your 
